JR

Jacques R. Seguin

Europe, England, United Kingdom, London

Description

Jacques Seguin is the Chairman Of The Board at Emanate Biomedical. He Attended Paris-Sud University (Paris XI) during 1975-1985.

Investor Profile

Jacques R. Seguin has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Pre Seed, Series Unknown rounds (top funding stages).
  • Majority of deals are located in Israel, Switzerland.
  • Strong thematic focus on Medical, Medical Device, Biotechnology.

Stage Focus

  • Seed (33%)
  • Pre Seed (33%)
  • Series Unknown (33%)

Country Focus

  • Israel (67%)
  • Switzerland (33%)

Industry Focus

  • Medical
  • Medical Device
  • Biotechnology
  • Health Diagnostics
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Jacques R. Seguin frequently co-invest with?

Peregrine Ventures
Asia, Tel Aviv, Israel, Or Yehuda
Co-Investments: 1
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1

Which angels does Jacques R. Seguin often collaborate with?

JL
Europe, France
Shared Deals: 1
Rafi Benary
Asia, Israel
Shared Deals: 1
AQ
North America, Connecticut, United States, West Hartford
Shared Deals: 1

What are some of recent deals done by Jacques R. Seguin?

Althea Medical

Tel Aviv, Tel Aviv, Israel

Althea Medical is a medical device start-up company.

Health DiagnosticsMedicalMedical Device
Pre SeedJun 1, 2023
Amount Raised: $1,500,000
Pi-Cardia

Herzliya, Tel Aviv, Israel

Pi-Cardia is a medical device start-up company developing a novel low profile catheter for the treatment of aortic stenosis.

Health CareMedicalMedical Device
Series UnknownApr 20, 2020
Amount Raised: $27,000,000
CorFlow Therapeutics AG

Baar, Zug, Switzerland

CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions.

BiotechnologyMedicalMedical Device
SeedOct 24, 2017
Amount Raised: $2,624,044

Find More Investors Like Jacques R. Seguin

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Jacques R. Seguin | Pipeseed